Reports for METHYLPHENIDATE HYDROCHLORIDE

Ingredient

METHYLPHENIDATE HYDROCHLORIDE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
FOQUEST 45MG CAPSULE (CONTROLLED RELEASE) Resolved 2021-11-29 2021-12-17 150147
FOQUEST 45MG CAPSULE (CONTROLLED RELEASE) Resolved 2022-01-11 2022-02-26 152465
FOQUEST 45MG CAPSULE (CONTROLLED RELEASE) Resolved 2022-03-21 2022-05-04 157052
FOQUEST 45MG CAPSULE (CONTROLLED RELEASE) Resolved 2022-05-20 2022-06-01 161057
FOQUEST 45MG CAPSULE (CONTROLLED RELEASE) Resolved 2023-02-09 2023-02-17 184298
FOQUEST 45MG CAPSULE (CONTROLLED RELEASE) Resolved 2023-04-05 2023-04-14 188874
FOQUEST 55MG CAPSULE (CONTROLLED RELEASE) Resolved 2022-01-11 2022-02-17 152470
FOQUEST 55MG CAPSULE (CONTROLLED RELEASE) Resolved 2022-03-25 2022-04-04 157368
FOQUEST 55MG CAPSULE (CONTROLLED RELEASE) Resolved 2022-07-22 2022-07-30 165258
FOQUEST 55MG CAPSULE (CONTROLLED RELEASE) Resolved 2022-08-18 2022-09-28 166986

Showing 1 to 10 of 196

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
RITALIN 10MG 10MG TABLET Discontinued 2022-02-08 2022-05-11 154449
RITALIN 20MG 20MG TABLET Discontinued 2019-07-22 2019-08-01 89771
METHYLPHENIDATE 5MG TABLET Discontinued 2019-04-10 2019-04-11 81132
METHYLPHENIDATE 10MG TABLET Discontinued 2019-04-10 2019-04-11 81136
METHYLPHENIDATE 20MG TABLET Discontinued 2019-04-10 2019-04-11 81139
RITALIN-SR TAB 20MG 20MG TABLET (EXTENDED-RELEASE) Discontinued 2022-02-08 2022-04-05 154439
PMS-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Discontinued 2020-06-17 2020-06-17 118105
PMS-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Discontinued 2020-06-17 2020-06-17 118099
PMS-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Discontinued 2020-06-17 2020-06-17 118108
PMS-METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Discontinued 2020-06-17 2020-06-17 118102

Showing 1 to 10 of 11